Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/58955
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ayako Sakakibara | en_US |
dc.contributor.author | Kei Kohno | en_US |
dc.contributor.author | Naoto Kuroda | en_US |
dc.contributor.author | Kenji Yorita | en_US |
dc.contributor.author | Nirmeen A. Megahed | en_US |
dc.contributor.author | Ahmed E. Eladl | en_US |
dc.contributor.author | Teerada Daroontum | en_US |
dc.contributor.author | Eri Ishikawa | en_US |
dc.contributor.author | Yuka Suzuki | en_US |
dc.contributor.author | Satoko Shimada | en_US |
dc.contributor.author | Masato Nakaguro | en_US |
dc.contributor.author | Yoshie Shimoyama | en_US |
dc.contributor.author | Akira Satou | en_US |
dc.contributor.author | Seiichi Kato | en_US |
dc.contributor.author | Yasushi Yatabe | en_US |
dc.contributor.author | Naoko Asano | en_US |
dc.contributor.author | Shigeo Nakamura | en_US |
dc.date.accessioned | 2018-09-05T04:35:36Z | - |
dc.date.available | 2018-09-05T04:35:36Z | - |
dc.date.issued | 2018-04-01 | en_US |
dc.identifier.issn | 14401827 | en_US |
dc.identifier.issn | 13205463 | en_US |
dc.identifier.other | 2-s2.0-85042410761 | en_US |
dc.identifier.other | 10.1111/pin.12653 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042410761&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/58955 | - |
dc.description.abstract | © 2018 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd The anaplastic variant of diffuse large B-cell lymphoma (A-DLBCL) is morphologically defined but remains an enigmatic disease in its clinicopathologic distinctiveness. Here, we report two cases involving Japanese women aged 59 years, both with A-DLBCL with the hallmark cell appearance and both indistinguishable from common and giant cell-rich patterns, respectively, of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma. Case 1 was immunohistochemically positive for CD20, CD79a and OCT-2 but not for the other pan–B-cell markers, CD30 and ALK. Case 2 showed CD20 and CD30 positivity for 50% and 20% of tumor cells in addition to strong expression of p53 and MYC. Both were positive for fascin without Epstein–Barr virus association. Our cases provide additional support for the earlier reports that A-DLBCL exhibits clinicopathologic features distinct from ordinal diffuse large B-cell lymphoma (DLBCL), and documented its broader morphologic diversity than previously recognized. They also shed light on the unique feature of absent expression of pan–B-cell markers except for CD20 and CD79a, suggesting that A-DLBCL may biologically mimic a gray zone or intermediate lymphoma between DLBCL and classic Hodgkin lymphoma. | en_US |
dc.subject | Medicine | en_US |
dc.title | Anaplastic variant of diffuse large B-cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Pathology International | en_US |
article.volume | 68 | en_US |
article.stream.affiliations | Nagoya University Hospital | en_US |
article.stream.affiliations | Okazaki City Hospital | en_US |
article.stream.affiliations | Kochi Red Cross Hospital | en_US |
article.stream.affiliations | Mansoura University, Faculty of Medicine | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | Aichi Medical University | en_US |
article.stream.affiliations | Aichi Cancer Center Hospital and Research Institute | en_US |
article.stream.affiliations | Nagano Prefectural Suzaka Hospital | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.